Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ybrain Inc.
With
The Catholic University of Korea
Inje University
Korea University
Seoul National University Bundang Hospital
Hallym University Medical Center
Soonchunhyang University Hospital
Patients received tDCS for 30 minutes with an intensity of 1.5 to 2 mA. tDCS was applied over the left (anode) and right (cathode) dorsolateral prefrontal cortex (DLPFC) 5\~7 times a week and they were evaluated every 2weeks through questionnaires.
Age
19–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has a diagnosis of a major depressive disorder as confirmed by the DSM-V and MINI (without psychotic features)
Patients with a K-BDI-II score of 14 or more and 28 or less
In the case of patients who have previously administered antidepressants, antipsychotics, and anticonvulsants for at least 1 week, Patients with sufficient drug treatment periods of at least 5 times the drug half-life.
You may not be if
Patients diagnosed with Axis I disorders other than major depressive disorder
Patients diagnosed with other depressive disorders besides major depressive disorder
Patients who have attempted suicide within 6 months of screening
Patients who are considered to have problems with EEG and DC stimulation electrode attachment due to scalp deformity, inflammatory reaction, or other dermatological problems
Patients judged to have other reasons for prohibition of use of tDCS medical devices
